Skip to content
IP + Technology Law
Home  »  News & Insights  »  Presentation

Developing Effective Patent Strategies for Personalized Medical Devices in Europe and the US

June 11, 2021  | Sabing Lee and Christy Lea

Attorneys Sabing Lee and Christy Lea presented a detailed webinar focusing on strategic considerations for medical device patents in Europe and the U.S.

Click on the image below to view live presentation.

HGF Presentation 6-21

View and download the full presentation below.
Developing Effective Patent Strategies for Personalized Medical Devices in Europe and the US

View on Slide share: Developing Effective Patent Strategies for Personalized Medical Devices in Europe and the US

View more Knobbe Martens slide presentations here.
Developing Effective Patent Strategies for Personalized Medical Devices in Europe and the US Headshot

Sabing Lee
Partner
Orange County
Sabing.Lee@knobbe.com
949-760-0404
Developing Effective Patent Strategies for Personalized Medical Devices in Europe and the US Headshot

Christy Lea
Partner
Orange County
Christy.Lea@knobbe.com
949-760-0404

Related Links

Practice Areas

Industries

News & Insights

Blog - Biotechnology
Aug 2025
Eyeing the Prize of the U.S. Patent System, the Trump Administration Proposes Patent Maintenance Fee Overhaul
The Trump administration is considering changing the U.S. patent maintenance fee structure from the existing three fixed flat fees to an annual, value‑based “tax” model where patent holders would pay...
Blog - Medical Devices & Procedures
Oct 2025
How to Measure Performance for AI-Enabled Medical Devices? FDA Seeks Public Input
On September 30, 2025, the U.S. Food and Drug Administration (FDA ) posted a Request for Public Comment regarding how to measure the performance of medical devices enabled with artificial intelligence (AI). The...
Publications
Oct 2025
USPTO Proposes Rule and Director Implements Policy Likely to Limit Multiple Patent Validity Challenges
On Friday, October 17, the USPTO published a proposed rule that, if implemented, would likely reduce filings of inter partes review patent validity challenges. In addition, USPTO Director John Squires...